 |
Himadri Biswas, Ph.D.
Zou lab, BHS 440, (419) 383-4164
himadri.biswas@utoledo.edu
Education:
B.S., 2004 - Microbiology, University of Calcutta, Kolkata, West Bengal, India
M.S., 2006 - Biotechnology, University of Burdwan, Purba Bardhaman, West Bengal, India
Ph.D., 2016 - Biochemistry, Univ of Calcutta, Kolkata, West Bengal, India
Research Interests: Eludicating the structure-function relationships of ATR (ataxia telangiectasia
and Rad3-related) prolyl isomers on carcinogenesis and tumorigenesis |
 |
Megan Dreier, Ph.D.
de la Serna lab, BHS 303, (419) 383-4133
megan.dreier@utoledo.edu
Education:
B.S., 05/2007 - Biology, University of Toledo, Toledo, Ohio
Ph.D., 05/2012 - Cell and Molecular Biology, University of Toledo
Research interests: Cell cycle and tumor biology; currently studying the effects of the inhibition
of chromatin regulators on melanocyte development in melanoma
|
 |
Shruti Ghai, Ph.D.
Su lab, BHS 466, (419) 383-4159
shrutirakesh.ghai@utoledo.edu
Education:
B.Tech, 2016 - D.Y. Patil University, Navi Mumbai, India
M.S., 2017 - Georgetown University, Washington, DC, USA
Ph.D., 2024 - University of Toledo, Cell & Cancer Biology, Toledo, OH, USA
|
|
|
Guoyi Jiang, Ph.D.
S-H Liu lab, HEB 225, (419) 383-6489
guoyi.jiang@utoledo.edu
Education:
Ph.D., 2024 - Pharmaceutics, University of Houston, College of Pharmacy, Houston,
TX
M.Med., 2017 - Pharmaceutical Analysis, Nanjing Medical University, Nanjing, China
B.S., 2014 - Pharmacy, Nanjing Medical University, Nanjing, China
Research interests:
I aim to innovate cancer therapy by harnessing exosomes as programmable drug delivery
vehicles. My research integrates molecular engineering, tumor immunology, and bioanalytical
science to overcome biological barriers in pancreatic cancer. I design targeting peptides
to enhance specificity and minimize immune clearance. Through advanced models and
pharmacokinetic tools, I translate bench discoveries toward personalized medicine.
My goal is to bridge nanotechnology and oncology for smarter, safer therapeutics. |
 |
Sophia Josephraj, Ph.D.
Zhang lab, BHS 435, (419) 383-4322
sophia.josephraj@utoledo.edu
Education:
B.S., 2010 - Biochemistry, Holy Cross College, Bharthidasan University, Tiruchirapalli,
Tamil Nadu, India
M.Sc., 2012 - Biochemistry, Holy Cross College, Bharthidasan University
M.Phil., 2013 - Biochemistry, Bharthidasan University
Ph.D., 2019 - Biochemistry, Annamalai University, Annamalainagar, Chidambaram, Tamil
Nadu, India
Research interests: 1) Kinase transcriptions factors in gene expression regulation, signal transduction,
cell growth and differentiation; 2) Multiple mechanisms of drug resistance in fatty
acid synthase
|
 |
Shobhit Srivastava, Ph.D.
Raman lab, BHS 405, (419) 383-4165
shobhit.srivastava@utoledo.edu
Education:
BPharm., 2008 - Uttar Pradesh Technical University, Lucknow, India
MPharm., 2010 - Uttar Pradesh Technical University, Lucknow, India
Ph.D., 2017 - King George's Medical University, Lucknow, India
Research Interests: Elucidation of mechanistic basis for drug-resistance mechanism in metastatic triple-negative
breast cancer (mTNBC) with an emphasis on targeting translation of oncogenic mRNAs;
pharmaceutical chemistry, drug design, evaluation of drug toxicity and metabolomics
|
 |
Min Tang, M.D.
Li lab, BHS 302, (419) 383-4446
min.tang@utoledo.edu
Education:
B.S., 2006 - Clinical Medicine, Luzhou Medical College, Sichuan, China
M.S., 2011 - Radiology, Chongqing Medical University, Chongqing, China
M.D., 2021 - Oncology, Chongqing Medical University, Chongqing, China
Research Interests: The impact of bone microenvionrment and therapies on prostate cancer metastasis,
dissemination, and dormancy.
|
 |
Harshini Vemula,Ph.D.
Saladi lab, BHS 371, (419) 383-6572
harshini.vemula@utoledo.edu
Education:
B.V.Sc., A.H. 2014 - Sri Venkateswara Veterinary University, Tirupati, India
M.V.Sc., 2017 - Sri Venkateswara Veterinary University, Tirupati, India
Ph.D., 2021 - Tamil Nadu Veterinary and Animal Sciences University, Chennai, India
Research Interests: Understanding mechanisms by which deregulated epigenetic factors (KDM4A and ACTL6A)
promote oncogenic transcriptional program.
|
 |
Xunzhen (Sean) Zheng, M.D.
JT Zhang lab, BHS 435, (419) 383-4322
xunzhen.zheng@utoledo.edu
Education:
M.S., M.D., 06/1997 - Hematology, Central South Univ, Xiangya Medical College, Changsha,
Hunan, China
Research Interests: The involvement of nitric oxide pathway in breast cancer development and treatment
|
